The patient’s symptoms suggest Landau-Kleffner syndrome, which requires an EEG for diagnosis. This rare disorder causes a child to lose both expressive and receptive language, despite previously developing normally. EEG abnormalities over Broca and Wernicke’s area, particularly during sleep, are common. Seizures may also occur before of after the onset of aphasia. While prognosis varies, Landau-Kleffner syndrome is typically not life-threatening. About two-thirds of children experience a receptive language deficit, while one-third recover completely. Treatment involves antiepileptic medication. CT and MRI scans, as well as CSF analysis, are typically normal. Speech and language therapy may be recommended as part of a multidisciplinary approach. However, EEG testing is essential for diagnosis.

ICD-10’s Anankastic personality disorder is the same as DSM V obsessive-compulsive personality disorder, while inadequate and passive aggressive personality disorders are not recognized in either classification system. Additionally, DSM V includes narcissistic personality disorder as a distinct category of personality disorder.

A positive Romberg test suggests the presence of sensory ataxia.

Romberg’s Test for Investigating Ataxia

Romberg’s test is a diagnostic tool used to determine the cause of ataxia. A positive result indicates that the cause is sensory in nature. The test involves asking the patient to stand upright with their feet together and eyes closed. If the patient begins to sway of fall over, the test is considered positive. In cases where there is a cerebellar problem, the patient will exhibit ataxia even when their eyes are open. Romberg’s test is an important tool in diagnosing ataxia and determining the underlying cause of the condition.

The inhibition of sexual behavior is caused by the activation of 5-HT2 receptors. However, this effect can be reversed by using 5-HT2 antagonists like cyproheptadine and 5-HT1a agonists like buspirone. These drugs are effective in treating sexual dysfunction caused by selective serotonin reuptake inhibitors (SSRIs).

Antidepressants can cause sexual dysfunction as a side-effect, although the rates vary. The impact on sexual desire, arousal, and orgasm can differ depending on the type of antidepressant. It is important to rule out other causes and consider non-pharmacological strategies such as reducing the dosage of taking drug holidays. If necessary, switching to a lower risk antidepressant of using pharmacological options such as phosphodiesterase inhibitors of mirtazapine augmentation can be considered. The Maudsley Guidelines 14th Edition provides a helpful table outlining the risk of sexual dysfunction for different antidepressants.

The most likely cause of the patient’s symptoms is alcohol dependence, which can lead to a depletion of B1 stores and result in Wernicke’s encephalopathy. While hypertension and type 2 diabetes are risk factors for vascular disease, they typically present with focal neurological signs rather than confusion. The patient’s triad of confusion, ataxia, and ophthalmoplegia, along with visual hallucinations and confabulation, suggest a Korsakoff’s psychosis, which can result from a thiamine deficiency. While anorexia nervosa can also cause B1 deficiency, it is an unlikely condition in an elderly gentleman, and other conditions causing malabsorption can also trigger Wernicke’s. While diabetics can experience delirium from low blood sugars and infections, the specific symptoms described here are not typical of these causes. While people with learning difficulties may be more prone to delirium with concurrent illness, it is not likely to cause the specific triad of symptoms seen in this patient.

Extrapyramidal side-effects (EPSE’s) are a group of side effects that affect voluntary motor control, commonly seen in patients taking antipsychotic drugs. EPSE’s include dystonias, parkinsonism, akathisia, and tardive dyskinesia. They can be frightening and uncomfortable, leading to problems with non-compliance and can even be life-threatening in the case of laryngeal dystonia. EPSE’s are thought to be due to antagonism of dopaminergic D2 receptors in the basal ganglia. Symptoms generally occur within the first few days of treatment, with dystonias appearing quickly, within a few hours of administration of the first dose. Newer antipsychotics tend to produce less EPSE’s, with clozapine carrying the lowest risk and haloperidol carrying the highest risk. Akathisia is the most resistant EPSE to treat. EPSE’s can also occur when antipsychotics are discontinued (withdrawal dystonia).

Cranial nerves III, IV and V exit from the pons, VI, VII, VIII exit from the pontomedullary junction and cranial nerve IX, X, XI, XII exit from the medulla.

Understanding Biotransformation: A Metabolic Process for Excretion

Biotransformation is a metabolic process that occurs primarily in the liver, but also in other organs such as the kidneys, intestine, adipose, skin, and lungs. Its main function is to facilitate the excretion of both exogenous and endogenous substances by altering their chemical structures through a series of reactions. Enzymes found in the cytoplasm, endoplasmic reticulum, and mitochondria of cells catalyze these reactions, which can cause the substrate to become inactive, active, of even toxic.

Biotransformation is divided into three phases. Phase I reactions involve oxidation, reduction, of hydrolysis of the drug, yielding a polar, water-soluble metabolite that is often still active. Phase II reactions consist of adding hydrophilic groups to the original molecule, a toxic intermediate, of a nontoxic metabolite formed in phase I, to increase its polarity. The most common method is conjugation with glucuronic acid, but other groups such as sulphate, amino acids, acetate, and methyl can also be added. Phase III reactions occur post-phase II, where a chemical substance can undergo further metabolism and excretion through active transport into the urinary of hepatobiliary system.

Understanding biotransformation is crucial in pharmacology and toxicology, as it affects the efficacy and toxicity of drugs and other substances. By facilitating the excretion of these substances, biotransformation helps maintain homeostasis in the body and prevent accumulation of potentially harmful compounds.

The First Pass Effect in Psychiatric Drugs

The first-pass effect is a process in drug metabolism that significantly reduces the concentration of a drug before it reaches the systemic circulation. This phenomenon is related to the liver and gut wall, which absorb and metabolize the drug before it can enter the bloodstream. Psychiatric drugs are not exempt from this effect, and some undergo a significant reduction in concentration before reaching their target site. Examples of psychiatric drugs that undergo a significant first-pass effect include imipramine, fluphenazine, morphine, diazepam, and buprenorphine. On the other hand, some drugs undergo little to no first-pass effect, such as lithium and pregabalin.

Orally administered drugs are the most affected by the first-pass effect. However, there are other routes of administration that can avoid of partly avoid this effect. These include sublingual, rectal (partly avoids first pass), intravenous, intramuscular, transdermal, and inhalation. Understanding the first-pass effect is crucial in drug development and administration, especially in psychiatric drugs, where the concentration of the drug can significantly affect its efficacy and safety.

The pupils are innervated by both sides of the midbrain and respond to ambient light levels. If there is an optic nerve lesion, the non-damaged nerve becomes dominant and both pupils respond to ambient light from that nerve. A helpful mnemonic for remembering the cranial nerves and their functions is OOOTTAFVGVAH for the nerves and SSMMBMBSBBMM for their functions. To recall the innervation of the extraocular muscles, one can use SO4 LR6. The optic nerve is II, oculomotor is III and supplies all extraocular muscles except for the superior oblique and lateral rectus, trochlear is IV and innervates the superior oblique muscle for depression and intorsion, trigeminal is V and supplies sensory information and muscles of mastication, and abducens is VI and controls the lateral rectus muscle of the eye.

Anxiety can also be caused by organic factors such as alcohol withdrawal, drug intoxication of withdrawal, thyrotoxicosis, and paroxysmal supraventricular tachycardias. While phaeochromocytoma is a rare cause, carcinoid does not typically result in anxiety. It is more common for depression to be a presenting symptom of carcinoma of the bronchus and hyperparathyroidism.

It is common for patients taking lithium to be inadequately monitored, which has prompted NICE and the National Patient Safety Agency (NPSA) to issue guidance on the matter. This topic is often tested in exams. According to NICE (CKS), lithium blood levels should be checked weekly until they become stable, and then every 3 months once they are stable. The levels should be taken 12 hours after the dose. Maudsley (13th) recommends checking levels every 6 months, but more frequent monitoring is necessary for those taking interacting drugs, the elderly, and those with established renal impairment of other relevant physical illness. The BNF recommends weekly monitoring until stable, and then every 3 months for the first year, followed by every 6 months thereafter. Patients should have their thyroid and renal function checked every 6 months, and they should be provided with an information booklet, alert card, and record book.

Lithium – Pharmacology

Pharmacokinetics:
Lithium salts are rapidly absorbed following oral administration and are almost exclusively excreted by the kidneys unchanged. Blood samples for lithium should be taken 12 hours post-dose.

Ebstein’s:
Ebstein’s anomaly is a congenital malformation consisting of a prolapse of the tricuspid valve into the right ventricle. It occurs in 1:20,000 of the general population. Initial data suggested it was more common in those using lithium but this had not held to be true.

Contraindications:
Addison’s disease, Brugada syndrome, cardiac disease associated with rhythm disorders, clinically significant renal impairment, untreated of untreatable hypothyroidism, low sodium levels.

Side-effects:
Common side effects include nausea, tremor, polyuria/polydipsia, rash/dermatitis, blurred vision, dizziness, decreased appetite, drowsiness, metallic taste, and diarrhea. Side-effects are often dose-related.

Long-term use is associated with hypothyroidism, hyperthyroidism, hypercalcemia/hyperparathyroidism, irreversible nephrogenic diabetes insipidus, and reduced GFR.

Lithium-induced diabetes insipidus:
Treatment options include stopping lithium (if feasible), keeping levels within 0.4-0.8 mmol/L, once-daily dose of the drug taken at bedtime, amiloride, thiazide diuretics, indomethacin, and desmopressin.

Toxicity:
Lithium salts have a narrow therapeutic/toxic ratio. Risk factors for lithium toxicity include drugs altering renal function, decreased circulating volume, infections, fever, decreased oral intake of water, renal insufficiency, and nephrogenic diabetes insipidus. Features of lithium toxicity include GI symptoms and neuro symptoms.

Pre-prescribing:
Before prescribing lithium, renal function, cardiac function, thyroid function, FBC, and BMI should be checked. Women of childbearing age should be advised regarding contraception, and information about toxicity should be provided.

Monitoring:
Lithium blood levels should be checked weekly until stable, and then every 3-6 months once stable. Thyroid and renal function should be checked every 6 months. Patients should be issued with an information booklet, alert card, and record book.

Greisinger, a prominent figure in 19th Century German psychiatry, is credited with establishing the first biological approach to psychiatry. He famously asserted that all mental disorders have their roots in brain pathology.

Creutzfeldt-Jakob Disease: Differences between vCJD and CJD

Creutzfeldt-Jakob Disease (CJD) is a prion disease that includes scrapie, BSE, and Kuru. However, there are important differences between sporadic (also known as classic) CJD and variant CJD. The table below summarizes these differences.

vCJD:
– Longer duration from onset of symptoms to death (a year of more)
– Presents with psychiatric and behavioral symptoms before neurological symptoms
– MRI shows pulvinar sign
– EEG shows generalized slowing
– Originates from infected meat products
– Affects younger people (age 25-30)

CJD:
– Shorter duration from onset of symptoms to death (a few months)
– Presents with neurological symptoms
– MRI shows bilateral anterior basal ganglia high signal
– EEG shows biphasic and triphasic waves 1-2 per second
– Originates from genetic mutation (bad luck)
– Affects older people (age 55-65)

Overall, understanding the differences between vCJD and CJD is important for diagnosis and treatment.

The plasma concentration is 50 and the total amount in the body is 1000, therefore the volume of distribution is 20.

Understanding the Volume of Distribution in Pharmacology

The volume of distribution (Vd) is a crucial concept in pharmacology that helps determine how a drug distributes in the body. It is also known as the apparent volume of distribution, as it is an abstract volume. The Vd indicates whether a drug concentrates in the plasma of spreads out in the body. Drugs that are highly polar tend to stay in central compartments such as the plasma, resulting in a low Vd. Conversely, drugs that are more lipid-soluble are distributed widely, such as in fat, resulting in a high Vd.

The Vd is calculated by dividing the amount of drug in the body by the concentration in the plasma. Clinically, the Vd is used to determine the loading dose of a drug required for a desired blood concentration and to estimate blood concentration in the treatment of overdose. The units of Vd are in volume.

The apparent volume of distribution is dependent on the drug’s lipid of water solubility, plasma protein binding, and tissue binding. Plasma protein binding affects the Vd, as drugs that bind to plasma proteins like albumin have a smaller apparent volume of distribution. This is because they are extracted from plasma and included in drug concentration measurements, which can give a misleading impression of their volume of distribution. Understanding the Vd is essential in pharmacology to ensure the safe and effective use of drugs.

To avoid potential liver damage, it is recommended to conduct liver function tests (LFTs) before starting agomelatine and periodically at 3, 6, 12, and 24 weeks after beginning treatment. If serum transaminases levels exceed three times the upper normal limit of if symptoms of liver disorder arise, agomelatine treatment should be discontinued.

The M phase is where cell division takes place through mitosis.

Cytokinesis: The Final Stage of Cell Division

Cytokinesis is the final stage of cell division, where the cell splits into two daughter cells, each with a nucleus. This process is essential for the growth and repair of tissues in multicellular organisms. In mitosis, cytokinesis occurs after telophase, while in meiosis, it occurs after telophase I and telophase II.

During cytokinesis, a contractile ring made of actin and myosin filaments forms around the cell’s equator, constricting it like a belt. This ring gradually tightens, pulling the cell membrane inward and creating a furrow that deepens until it reaches the center of the cell. Eventually, the furrow meets in the middle, dividing the cell into two daughter cells.

In animal cells, cytokinesis is achieved by the formation of a cleavage furrow, while in plant cells, a cell plate forms between the two daughter nuclei, which eventually develops into a new cell wall. The timing and mechanism of cytokinesis are tightly regulated by a complex network of proteins and signaling pathways, ensuring that each daughter cell receives the correct amount of cytoplasm and organelles.

Overall, cytokinesis is a crucial step in the cell cycle, ensuring that genetic material is equally distributed between daughter cells and allowing for the growth and development of multicellular organisms.

The sensation of insects crawling on of under the skin is known as formication and is often linked to alcohol withdrawal of delirium. Briquet’s syndrome is a type of somatisation disorder. Jamais vu is a phenomenon where a person recognizes a situation but feels unfamiliar with it, which can be a normal experience. Lilliputian hallucinations, which involve seeing miniature people of animals, may be a symptom of temporal lobe epilepsy.

The presence of spongiform (vacuolation) change is a highly specific indicator of prion diseases. While neuronal loss and gliosis are common in many CNS disorders, spongiform change is unique to prion diseases. This change is characterized by the appearance of vacuoles in the deep cortical layers, cerebellar cortex, of subcortical grey matter. Scar formation and acute immune responses are associated with reactive proliferation of astrocytes and microglia, respectively. In contrast, Alzheimer’s dementia is characterized by the presence of amyloid plaques.

The fusiform gyrus is essential for recognizing faces and bodies, while damage to the angular gyrus can result in Gerstmann syndrome.

The Cingulate Gyrus: A Hub for Emotions and Decision Making

The cingulate gyrus is a cortical fold located on the medial aspect of the cerebral hemisphere, adjacent to the corpus callosum. As part of the limbic system, it plays a crucial role in processing emotions and regulating the body’s endocrine and autonomic responses to emotional stimuli. Additionally, it is involved in reward-based decision making. Essentially, the cingulate gyrus acts as a hub that connects emotions, sensations, and actions. The term cingulate comes from the Latin word for belt of girdle, which reflects the way in which it wraps around the corpus callosum.

All the above are true for the formation of CSF

Benzodiazepines are a class of drugs commonly used to treat anxiety and sleep disorders. It is important to have a working knowledge of the more common benzodiazepines and their half-life. Half-life refers to the amount of time it takes for half of the drug to be eliminated from the body.

Some of the more common benzodiazepines and their half-life include diazepam with a half-life of 20-100 hours, clonazepam with a half-life of 18-50 hours, chlordiazepoxide with a half-life of 5-30 hours, nitrazepam with a half-life of 15-38 hours, temazepam with a half-life of 8-22 hours, lorazepam with a half-life of 10-20 hours, alprazolam with a half-life of 10-15 hours, oxazepam with a half-life of 6-10 hours, zopiclone with a half-life of 5-6 hours, zolpidem with a half-life of 2 hours, and zaleplon with a half-life of 2 hours. Understanding the half-life of these drugs is important for determining dosages and timing of administration.

The previously assumed higher risk is now uncertain and may not actually exist. We include this question to ensure that you are aware of the past association, as it may still be present in exam materials that have not been revised.

Lithium – Pharmacology

Pharmacokinetics:
Lithium salts are rapidly absorbed following oral administration and are almost exclusively excreted by the kidneys unchanged. Blood samples for lithium should be taken 12 hours post-dose.

Ebstein’s:
Ebstein’s anomaly is a congenital malformation consisting of a prolapse of the tricuspid valve into the right ventricle. It occurs in 1:20,000 of the general population. Initial data suggested it was more common in those using lithium but this had not held to be true.

Contraindications:
Addison’s disease, Brugada syndrome, cardiac disease associated with rhythm disorders, clinically significant renal impairment, untreated of untreatable hypothyroidism, low sodium levels.

Side-effects:
Common side effects include nausea, tremor, polyuria/polydipsia, rash/dermatitis, blurred vision, dizziness, decreased appetite, drowsiness, metallic taste, and diarrhea. Side-effects are often dose-related.

Long-term use is associated with hypothyroidism, hyperthyroidism, hypercalcemia/hyperparathyroidism, irreversible nephrogenic diabetes insipidus, and reduced GFR.

Lithium-induced diabetes insipidus:
Treatment options include stopping lithium (if feasible), keeping levels within 0.4-0.8 mmol/L, once-daily dose of the drug taken at bedtime, amiloride, thiazide diuretics, indomethacin, and desmopressin.

Toxicity:
Lithium salts have a narrow therapeutic/toxic ratio. Risk factors for lithium toxicity include drugs altering renal function, decreased circulating volume, infections, fever, decreased oral intake of water, renal insufficiency, and nephrogenic diabetes insipidus. Features of lithium toxicity include GI symptoms and neuro symptoms.

Pre-prescribing:
Before prescribing lithium, renal function, cardiac function, thyroid function, FBC, and BMI should be checked. Women of childbearing age should be advised regarding contraception, and information about toxicity should be provided.

Monitoring:
Lithium blood levels should be checked weekly until stable, and then every 3-6 months once stable. Thyroid and renal function should be checked every 6 months. Patients should be issued with an information booklet, alert card, and record book.

The Geriatric Mental State Schedule (GMSS) is a tool utilized to detect signs of depression among older adults.

In psychiatry, various questionnaires and interviews are used to assess different conditions and areas. It is important for candidates to know whether certain assessment tools are self-rated of require clinical assistance. The table provided by the college lists some of the commonly used assessment tools and indicates whether they are self-rated of clinician-rated. For example, the HAMD and MADRS are clinician-rated scales used to assess the severity of depression, while the GDS is a self-rated scale used to screen for depression in the elderly. The YMRS is a clinician-rated scale used to assess the severity of mania in patients with bipolar disorder, while the Y-BOCS is used to measure both the severity of OCD and the response to treatment. The GAF provides a single measure of global functioning, while the CGI requires the clinician to rate the severity of the patient’s illness at the time of assessment. The CAMDEX is a tool developed to assist in the early diagnosis and measurement of dementia in the elderly.

Synaptic plasticity is an important neurochemical foundation of working memory and generation of memory. Synaptic plasticity is the ability of synapses to strengthen or weaken over time in response to increases or decreases in their activity.

Macrocephaly is a characteristic often seen in individuals with Fragile X syndrome.

Microcephaly: A Condition of Small Head Size

Microcephaly is a condition characterized by a small head size. It can be a feature of various conditions, including fetal alcohol syndrome, Down’s syndrome, Edward’s syndrome, Patau syndrome, Angelman syndrome, De Lange syndrome, Prader-Willi syndrome, and Cri-du-chat syndrome. Each of these conditions has its own unique set of symptoms and causes, but they all share the common feature of microcephaly. This condition can have a range of effects on a person’s development, including intellectual disability, seizures, and motor problems. Early diagnosis and intervention can help manage the symptoms and improve outcomes for individuals with microcephaly.

MAOIs: A Guide to Mechanism of Action, Adverse Effects, and Dietary Restrictions

First introduced in the 1950s, MAOIs were the first antidepressants introduced. However, they are not the first choice in treating mental health disorders due to several dietary restrictions and safety concerns. They are only a treatment option when all other medications are unsuccessful. MAOIs may be particularly useful in atypical depression (over eating / over sleeping, mood reactivity).

MAOIs block the monoamine oxidase enzyme, which breaks down different types of neurotransmitters from the brain: norepinephrine, serotonin, dopamine, as well as tyramine. There are two types of monoamine oxidase, A and B. The MOA A are mostly distributed in the placenta, gut, and liver, but MOA B is present in the brain, liver, and platelets. Selegiline and rasagiline are irreversible and selective inhibitors of MAO type B, but safinamide is a reversible and selective MAO B inhibitor.

The most common adverse effects of MAOIs occurring early in treatment are orthostatic hypotension, daytime sleepiness, insomnia, and nausea; later common effects include weight gain, muscle pain, myoclonus, paraesthesia, and sexual dysfunction.

Pharmacodynamic interactions with MAOIs can cause two types of problem: serotonin syndrome (mainly due to SSRIs) and elevated blood pressure (caused by indirectly acting sympathomimetic amines releasers, like pseudoephedrine and phenylephrine). The combination of MAOIs and some TCAs appears safe. Only those TCAs with significant serotonin reuptake inhibition (clomipramine and imipramine) are likely to increase the risk of serotonin syndrome.

Tyramine is a monoamine found in various foods, and is an indirect sympathomimetic that can cause a hypertensive reaction in patients receiving MAOI therapy. For this reason, dietary restrictions are required for patients receiving MAOIs. These restrictions include avoiding matured/aged cheese, fermented sausage, improperly stored meat, fava of broad bean pods, and certain drinks such as on-tap beer. Allowed foods include fresh cottage cheese, processed cheese slices, fresh packaged of processed meat, and other alcohol (no more than two bottled or canned beers of two standard glasses of wine, per day).

Research has not found a higher incidence of childhood physical of sexual abuse in individuals with anorexia nervosa compared to those with other psychiatric conditions. However, there are several factors that may contribute to the development of anorexia nervosa, including being female, cultural influences (such as pressure to conform to certain body ideals in certain professions), family issues (such as poor communication and overprotectiveness), and individual factors (such as early dietary problems and parental preoccupation with food of dieting). In some cases, specific triggers such as weight loss after an illness of bullying may also be identified.

Frontal lobe pathology can result in the elicitation of frontal release signs, such as palmomental reflexes. Ataxia may be present in conditions like normal pressure hydrocephalus, while cogwheel rigidity is commonly found in extrapyramidal syndromes. Contralateral hemisphere dysfunction can lead to postural arm drift. These signs occur when the frontal lobe’s normal inhibition of these responses is released. For more information, see Kipps and Hodges’ article Cognitive assessment for clinicians.

To confirm a diagnosis of variant CJD, a tonsillar biopsy is performed as it is the only form of CJD that impacts the lymph nodes.

Creutzfeldt-Jakob Disease: Differences between vCJD and CJD

Creutzfeldt-Jakob Disease (CJD) is a prion disease that includes scrapie, BSE, and Kuru. However, there are important differences between sporadic (also known as classic) CJD and variant CJD. The table below summarizes these differences.

vCJD:
– Longer duration from onset of symptoms to death (a year of more)
– Presents with psychiatric and behavioral symptoms before neurological symptoms
– MRI shows pulvinar sign
– EEG shows generalized slowing
– Originates from infected meat products
– Affects younger people (age 25-30)

CJD:
– Shorter duration from onset of symptoms to death (a few months)
– Presents with neurological symptoms
– MRI shows bilateral anterior basal ganglia high signal
– EEG shows biphasic and triphasic waves 1-2 per second
– Originates from genetic mutation (bad luck)
– Affects older people (age 55-65)

Overall, understanding the differences between vCJD and CJD is important for diagnosis and treatment.

The heritability estimate does not provide any information about specific individuals.

Heritability: Understanding the Concept

Heritability is a concept that is often misunderstood. It is not a measure of the extent to which genes cause a condition in an individual. Rather, it is the proportion of phenotypic variance attributable to genetic variance. In other words, it tells us how much of the variation in a condition seen in a population is due to genetic factors. Heritability is calculated using statistical techniques and can range from 0.0 to 1.0. For human behavior, most estimates of heritability fall in the moderate range of .30 to .60.

The quantity (1.0 – heritability) gives the environment ability of the trait. This is the proportion of phenotypic variance attributable to environmental variance. The following table provides estimates of heritability for major conditions:

Condition Heritability estimate (approx)
ADHD 85%
Autism 70%
Schizophrenia 55%
Bipolar 55%
Anorexia 35%
Alcohol dependence 35%
Major depression 30%
OCD 25%

It is important to note that heritability tells us nothing about individuals. It is a population-level measure that helps us understand the relative contributions of genetic and environmental factors to a particular condition.

Pharmacokinetics includes the study of drug metabolism.

Receptor Binding

Receptor binding is a crucial aspect of pharmacodynamics, which involves the study of how drugs affect the body. Receptors are specialized proteins located on the surface of inside cells that interact with specific molecules, such as neurotransmitters, hormones, of drugs. When a drug binds to a receptor, it can either activate or inhibit its function, leading to various biological effects. The affinity and efficacy of a drug for a receptor depend on its chemical structure, concentration, and the properties of the receptor. Understanding receptor binding is essential for developing safe and effective drugs, as well as for predicting drug interactions and side effects.

Neurotransmitters are substances used by neurons to communicate with each other and with target tissues. They are synthesized and released from nerve endings into the synaptic cleft, where they bind to receptor proteins in the cellular membrane of the target tissue. Neurotransmitters can be classified into different types, including small molecules (such as acetylcholine, dopamine, norepinephrine, serotonin, and GABA) and large molecules (such as neuropeptides). They can also be classified as excitatory or inhibitory. Receptors can be ionotropic or metabotropic, and the effects of neurotransmitters can be fast of slow. Some important neurotransmitters include acetylcholine, dopamine, GABA, norepinephrine, and serotonin. Each neurotransmitter has a specific synthesis, breakdown, and receptor type. Understanding neurotransmitters is important for understanding the function of the nervous system and for developing treatments for neurological and psychiatric disorders.

Hypocretin deficiency has been linked to narcolepsy, as it is a neuropeptide hormone produced in the hypothalamus that plays a crucial role in regulating sleep, arousal, appetite, and energy expenditure (also known as orexin) (Mignot, 2000).

Sleep Disorders

The International Classification of Sleep Disorders (ISCD) categorizes sleep disorders into several main categories and subclasses. Dyssomnias are intrinsic sleep disorders that include narcolepsy, psychopsychologic insomnia, idiopathic hypersomnia, restless leg syndrome, periodic limb movement disorder, and obstructive sleep apnea. Extrinsic sleep disorders include inadequate sleep hygiene and alcohol-dependent sleep disorder. Circadian rhythm disorders consist of jet lag syndrome, shift work sleep disorder, irregular sleep-wake pattern, delayed sleep phase syndrome, and advanced sleep phase disorder. Parasomnias include arousal disorders such as sleepwalking and sleep terrors, sleep-wake transition disorders such as rhythmic movement disorder, sleep talking, and nocturnal leg cramps, and parasomnias associated with REM sleep such as nightmares and sleep paralysis. Sleep disorders associated with medical/psychiatric disorders and proposed sleep disorders are also included in the classification.

Narcolepsy is a disorder of unknown cause that is characterized by excessive sleepiness, cataplexy, and other REM sleep phenomena such as sleep paralysis and hypnagogic hallucinations. Periodic limb movement disorder is characterized by periodic episodes of repetitive and highly stereotyped limb movements that occur during sleep. Restless legs syndrome is a disorder characterized by disagreeable leg sensations that usually occur prior to sleep onset and that cause an almost irresistible urge to move the legs. Jet lag syndrome consists of varying degrees of difficulties in initiating or maintaining sleep, excessive sleepiness, decrements in subjective daytime alertness and performance, and somatic symptoms following rapid travel across multiple time zones. Shift work sleep disorder consists of symptoms of insomnia of excessive sleepiness that occur as transient phenomena in relation to work schedules. Non 24 hour sleep wake syndrome consists of a chronic steady pattern comprising one to two hour daily delays in sleep onset and wake times in an individual living in society. Sleepwalking consists of a series of complex behaviors that are initiated during slow-wave sleep and result in walking during sleep. Sleep terrors are characterized by a sudden arousal from slow wave sleep with a piercing scream of cry, accompanied by autonomic and behavioral manifestations of intense fear. Rhythmic movement disorder comprises a group of stereotyped, repetitive movements involving large muscles, usually of the head and neck. Sleep starts are sudden, brief contractions of the legs, sometimes also involving the arms and head, that occur at sleep onset. Nocturnal leg cramps are painful sensations of muscular tightness of tension, usually in the calf but occasionally in the foot, that occur during the sleep episode. Nightmares are frightening dreams that usually awaken the sleeper from REM sleep. Sleep paralysis is a common condition characterized by transient paralysis of skeletal muscles which occurs when awakening from sleep of less often while falling asleep.

According to the Maudsley Guidelines, it is recommended to administer a test dose for all first generation antipsychotics. Following the test dose, it is advised to wait 4-10 days before administering the next dose.

, coma, respiratory depression (rare)

Linguistic Development and Risk Factors for Delayed Speech and Language

The development of language skills is an important aspect of a child’s growth. The prelinguistic period, from birth to 12 months, is marked by crying, babbling, and echolalia. From 6 to 12 months, a child responds to their name and can differentiate between angry and friendly tones. By 18 to 24 months, a child can use up to 40-50 words, mainly nouns, and starts to combine words in short phrases. By 36 to 48 months, a child has a vocabulary of 900-1000 words, can use plurals and past tense, and can handle three-word sentences easily.

However, there are risk factors associated with delayed speech and language development. These include a positive family history, male gender, twins, lower maternal education, childhood illness, being born late in the family order, young mother at birth, and low socioeconomic status. of these, a positive family history is considered the most reliable risk factor. It is important to monitor a child’s language development and seek professional help if there are concerns about delayed speech and language.

Bupropion is classified as a noradrenaline dopamine reuptake inhibitor (NDRI) and functions by elevating the levels of neurotransmitters such as noradrenaline and dopamine. It has been utilized as an antidepressant and a smoking cessation aid.

Extrapyramidal side-effects (EPSE’s) are a group of side effects that affect voluntary motor control, commonly seen in patients taking antipsychotic drugs. EPSE’s include dystonias, parkinsonism, akathisia, and tardive dyskinesia. They can be frightening and uncomfortable, leading to problems with non-compliance and can even be life-threatening in the case of laryngeal dystonia. EPSE’s are thought to be due to antagonism of dopaminergic D2 receptors in the basal ganglia. Symptoms generally occur within the first few days of treatment, with dystonias appearing quickly, within a few hours of administration of the first dose. Newer antipsychotics tend to produce less EPSE’s, with clozapine carrying the lowest risk and haloperidol carrying the highest risk. Akathisia is the most resistant EPSE to treat. EPSE’s can also occur when antipsychotics are discontinued (withdrawal dystonia).

The glossopharyngeal nerve is a mixed nerve consisting of both sensory and motor fibers. It has several branches and five distinct general functions:
Branchial motor- Special visceral efferent- supplies the Stylopharyngeus muscle and superior constrictor muscle.
Visceral motor- general visceral efferent- provides parasympathetic innervation of the parotid gland.
Visceral sensory- general visceral afferent- carries visceral sensory information from the carotid sinus and carotid body.
General sensory- general somatic afferent- provides general sensory information from the inner surface of the tympanic membrane, upper pharynx and posterior one third of the tongue.
Visceral afferent- special visceral afferent- provides taste sensation from the posterior one third of the tongue including the circumvallate papillae.

Clinical Trials: Phases and Objectives

Clinical trials are conducted in four phases to evaluate the safety and efficacy of drugs of treatments. In Phase I, a small group of healthy individuals (15-20) is given the drug to determine its safety, dosage range, and side effects. Phase II involves a larger group (100-300) to assess the drug’s effectiveness and safety. In Phase III, the drug is given to a larger population (1,000-3,000) to confirm its efficacy, compare it with existing treatments, and collect data for safe use. Phase IV, also known as post-marketing trials, is conducted after the drug is licensed to gather additional information on safety and potential uses. These trials are crucial in determining the safety and efficacy of drugs and treatments before they are made available to the public.

Histamine, serotonin, bradykinin and prostaglandin are all chemical mediators of inflammation with different distinct functions however all activate nociceptors. Calcium on the other hand cannot sensitize or activate nociceptors.

Pareidolic illusions are vivid illusions that can occur from indistinct stimuli, such as seeing a face in the clouds. These illusions are a result of fantasy and vivid visual imagery and can intensify with concentration. Affect illusions arise from a particular mood state and disappear with concentration. Autoscopic hallucinations involve seeing oneself, such as in an out-of-body experience. Charles Bonnet syndrome is a type of hallucination that occurs in elderly people with reduced visual acuity. Complete illusions occur in the context of inattention, where an incomplete stimulus is perceived as complete. For more information, refer to Casey PR and Kelly B’s book, Fish’s Clinical Psychopathology: Signs and Symptoms in Psychiatry.

Confirmation of lithium toxicity cannot be solely based on a normal serum lithium level. EEG is a more reliable method, as it can detect diffuse slowing and triphasic waves, which are characteristic features of lithium toxicity. CT and MRI brain scans are not helpful in confirming lithium toxicity. While ECG may show changes such as arrhythmias and flattened of inverted T-waves, they are not sufficient to confirm lithium toxicity. A lumbar puncture can rule out an infectious cause for the symptoms but cannot confirm lithium toxicity.

Alpha-1 adrenergic receptors cause uterine contraction during pregnancy. They are linked to Gq-proteins that activate smooth muscle contraction through the IP3 signal transduction pathway.

Patients may feel that they have lost control over their thoughts, which can manifest as passivity of thought. This refers to the belief that an external agency is controlling one’s thoughts. Passivity can take different forms, such as thought withdrawal, thought insertion, and thought broadcasting.

Ego (Boundary) Disturbances

Ego (boundary) disturbances refer to experiences where there is a disturbance in the perception of self as distinct from the environment of the integrity of self. It also includes instances where bodily processes, personal thought processes, feelings, and actions are experienced as being externally directed. These phenomena are referred to as passivity phenomena, and some of the symptom characteristics are classified as bizarre delusional phenomena in the DSM.

Derealization is when a patient experiences their surroundings of time as if they are unreal and changed, losing all feelings of familiarity and trust in the environment. People, objects, and surroundings appear unreal, unfamiliar, of spatially altered. The sensations may be intense of weak in nature.

Depersonalization is when a patient perceives themselves as alien, unreal, changed, of as a stranger. The disturbances of depersonalization may be of a transient nature only of become more persistent over a longer period of time. It is generally felt to be both strange and unpleasant.

Thought broadcasting is when a patient’s personal thoughts are experienced as no longer belonging to the patient alone but accessible by others who will know what the patient is thinking (mind reading). Thought withdrawal is when a patient’s thoughts are being removed of stripped from them. Thought insertion is when patients experience their thoughts and ideas as being externally influenced, made externally, controlled, directed, entered/ of externally imposed.

Other feelings of alien influence refer to feelings, intentions, behavior, of bodily functions that are experienced as externally controlled of made by others (passivity phenomena). The patient feels externally compelled to say something specific, to scream, to act of behave in a particular way, to attack someone, to throw a tantrum, etc.

Opioid Pharmacology and Treatment Medications

Opioids work by binding to opioid receptors in the brain, specifically the µ, k, and δ receptors. The µ receptor is the main target for opioids and mediates euphoria, respiratory depression, and dependence. Dopaminergic cells in the ventral tegmental area produce dopamine, which is released into the nucleus accumbens upon stimulation of µ receptors, leading to the reward and euphoria that drives repeated use. However, with repeated exposure, µ receptors become less responsive, leading to dysphoria and drug craving.

There are several medications used in opioid treatment. Methadone is a full agonist targeting µ receptors, with some action against k and δ receptors, and has a half-life of 15-22 hours. However, it carries a risk of respiratory depression, especially when used with hypnotics and alcohol. Buprenorphine is a partial agonist targeting µ receptors, as well as a partial k agonist of functional antagonist and a weak δ antagonist. It has a high affinity for µ receptors and a longer half-life of 24-42 hours, making it safer than methadone. Naloxone is an antagonist targeting all opioid receptors and is used to reverse opioid overdose, with a half-life of 30-120 minutes. However, it can cause noncardiogenic pulmonary edema in some cases. Naltrexone is a reversible competitive antagonist at µ and ĸ receptors, with a half-life of 4-6 hours, and is used as an adjunctive prophylactic treatment for detoxified formerly opioid-dependent people.

Alpha2 adrenergic agonists, such as clonidine and lofexidine, can ameliorate opioid withdrawal symptoms associated with the noradrenaline system, including sweating, shivering, and runny nose and eyes. The locus coeruleus, a nucleus in the pons with a high density of noradrenergic neurons possessing µ-opioid receptors, is involved in wakefulness, blood pressure, breathing, and overall alertness. Exposure to opioids results in heightened neuronal activity of the nucleus cells, and if opioids are not present to suppress this activity, increased amounts of norepinephrine are released, leading to withdrawal symptoms. Clonidine was originally developed as an antihypertensive, but its antihypertensive effects are problematic in detox, so lofexidine was developed as an alternative with less hypotensive effects.

Delusions are false beliefs that are fixed and can be categorized as primary of secondary. Primary delusions include delusional intuition, delusional perception, delusional atmosphere, and delusional memory. Delusional atmosphere refers to a feeling that something is not right in the world around the patient, without any change in perception. Delusional intuition arises suddenly and occurs in a single stage, while delusional perception is a two-stage phenomenon where the patient misinterprets a normal perception with a delusional meaning. Delusional memory involves remembering past events with a delusional meaning. An example of delusional perception is when a patient misinterprets the marks of freckles and believes that water is being taken out of their body.

Neurotrophins: Crucial for Neuronal Growth and Development

Neurotrophins are essential for the growth and development of neurons. However, disturbances in neurotrophic factors may contribute to some neurodevelopmental aspects of schizophrenia and major depression.

Studies have shown that patients with schizophrenia have increased concentrations of Brain-derived neurotrophic factor (BDNF) in cortical areas, but decreased levels in the hippocampus compared to controls. Additionally, patients with schizophrenia have lower concentrations of neurotrophin-3 in frontal and parietal areas than controls.

These findings suggest that neurotrophins play a critical role in the pathophysiology of schizophrenia and major depression. Further research is needed to fully understand the mechanisms underlying these disturbances in neurotrophic factors.

Agomelatine (Valdoxan) is a novel antidepressant that functions as an agonist at both MT1 and MT2 receptors, while also acting as a 5HT2C antagonist. Unlike most other antidepressants, it does not affect monoamine uptake.
First-generation antipsychotics work by antagonizing D2 receptors.
Benzodiazepines exert their effects by potentiating GABA.
Noradrenaline reuptake inhibition is a common mechanism of action for many antidepressants, including SNRIs and tricyclics.
SSRI (and other) antidepressants function by inhibiting the reuptake of serotonin.

Understanding Wilson’s Disease: Causes, Symptoms, and Management

Wilson’s disease, also known as hepatolenticular degeneration, is a genetic disorder that affects copper storage in the body. This condition is caused by a defect in the ATP7B gene, which leads to the accumulation of copper in the liver and brain. The onset of symptoms usually occurs between the ages of 10 and 25, with liver disease being the most common presentation in children and neurological symptoms in young adults.

The excessive deposition of copper in the tissues can cause a range of symptoms, including hepatitis, cirrhosis, basal ganglia degeneration, speech and behavioral problems, asterixis, chorea, dementia, Kayser-Fleischer rings, sunflower cataract, renal tubular acidosis, haemolysis, and blue nails. Diagnosis is based on reduced serum ceruloplasmin, reduced serum copper, and increased 24-hour urinary copper excretion.

The traditional first-line treatment for Wilson’s disease is penicillamine, which chelates copper. Trientine hydrochloride is an alternative chelating agent that may become first-line treatment in the future. Tetrathiomolybdate is a newer agent that is currently under investigation.

In summary, Wilson’s disease is a genetic disorder that affects copper storage in the body, leading to a range of symptoms that can affect the liver, brain, and eyes. Early diagnosis and treatment are essential to prevent complications and improve outcomes.